IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Skye Bioscience Inc (SKYE)

CUSIP: 83086J200 | NYSE | Healthcare · Biotechnology | Micro Cap | 144 institutional holders

Quarters

Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Beneficial Ownership — 13D / 13G

Full history →

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

HolderShares% of ClassChangeEvent Datevs 13F
13D/AAndrew J. Schwab
with 5AM Ventures VII, L.P., 5AM Partners VII, LLC, Kush Parmar, +5 more
11,273,40730.2%−267,910Aug 14, 2026No 13F filer matched
13D/A

Institutional Holders — Q3 2026

IFP Advisors, Inc1
0.0% of portfolio›$0
StyleTurnoverLocationFiled
IFP Advisors, Inc
1$00.0%GrowthLowTampa, FL2026-10-16
Andrew J. Schwab
11,273,407
30.2% of class · Aug 14, 2026−267,910
with 5AM Ventures VII, L.P., 5AM Partners VII, LLC, Kush Parmar, +5 more
No 13F filer matched